| 1 | 17875710 | MicroRNA signatures in human ovarian cancer. | Cancer Res | 2007 Sep 15 |
1 |
| 2 | 19276373 | microRNA-205 regulates HER3 in human breast cancer. | Cancer Res | 2009 Mar 15 |
2 |
| 3 | 20428818 | Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. | Oncol Rep | 2010 Jun |
2 |
| 4 | 21368878 | Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. | Cell Death Dis | 2010 Dec 9 |
1 |
| 5 | 21787752 | ErbB2 down-regulates microRNA-205 in breast cancer. | Biochem Biophys Res Commun | 2011 Aug 12 |
1 |
| 6 | 22356767 | Metformin lowers the threshold for stress-induced senescence: a role for the microRNA-200 family and miR-205. | Cell Cycle | 2012 Mar 15 |
2 |
| 7 | 22859986 | Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells. | PLoS One | 2012 |
3 |
| 8 | 23041061 | Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205. | Am J Pathol | 2012 Dec |
1 |
| 9 | 23073476 | miRNA profiling in pancreatic cancer and restoration of chemosensitivity. | Cancer Lett | 2013 Jul 1 |
1 |
| 10 | 23564023 | SZ-685C exhibits potent anticancer activity in both radiosensitive and radioresistant NPC cells through the miR-205-PTEN-Akt pathway. | Oncol Rep | 2013 Jun |
2 |
| 11 | 23612742 | MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. | Int J Oncol | 2013 Jul |
2 |
| 12 | 23629002 | Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo. | Mol Ther | 2013 Jun |
1 |
| 13 | 23856247 | miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. | Cancer Res | 2013 Sep 1 |
1 |
| 14 | 23898078 | Evaluation of MicroRNA expression pattern of gastric adenocarcinoma associated with socioeconomic, environmental and lifestyle factors in northwestern Hungary. | Anticancer Res | 2013 Aug |
1 |
| 15 | 23950153 | Inhibition of miR-205 impairs the wound-healing process in human corneal epithelial cells by targeting KIR4.1 (KCNJ10). | Invest Ophthalmol Vis Sci | 2013 Sep 11 |
1 |
| 16 | 24098490 | Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. | PLoS One | 2013 |
4 |
| 17 | 24147037 | miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells. | PLoS One | 2013 |
1 |
| 18 | 24370341 | miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells. | Biochem Pharmacol | 2014 Feb 15 |
3 |
| 19 | 24396484 | 5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells. | Oncol Lett | 2014 Feb |
2 |
| 20 | 24462768 | MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. | Biochem Biophys Res Commun | 2014 Feb 7 |
3 |
| 21 | 24576478 | Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4. | Biochem Biophys Res Commun | 2014 Mar 14 |
6 |
| 22 | 24911146 | CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance. | J Clin Invest | 2014 Jul |
1 |
| 23 | 25012146 | MicroRNA-205 regulates the calcification and osteoblastic differentiation of vascular smooth muscle cells. | Cell Physiol Biochem | 2014 |
4 |
| 24 | 25137071 | Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel. | PLoS One | 2014 |
4 |
| 25 | 25427583 | miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma. | Oncol Res Treat | 2014 |
1 |
| 26 | 25586904 | Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use. | Cancer Prev Res (Phila) | 2015 Mar |
2 |
| 27 | 25633049 | MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. | Breast Cancer Res | 2015 Jan 30 |
2 |
| 28 | 25667498 | Alteration of miRNA expression correlates with lifestyle, social and environmental determinants in esophageal carcinoma. | Anticancer Res | 2015 Feb |
1 |
| 29 | 25736407 | Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis. | J Nutr Biochem | 2015 May |
1 |
| 30 | 25792283 | Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. | J Nutr Biochem | 2015 Jun |
1 |
| 31 | 25917317 | MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells. | Cell Signal | 2015 Aug |
2 |
| 32 | 26252115 | MicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1. | Mol Med Rep | 2015 Oct |
1 |
| 33 | 26305791 | Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel. | PLoS One | 2015 |
2 |
| 34 | 26469956 | Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer. | Cell Death Dis | 2015 Oct 15 |
2 |
| 35 | 26715266 | Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer. | Tumour Biol | 2016 Jun |
2 |
| 36 | 26893700 | MicroRNA-205 increases the sensitivity of docetaxel in breast cancer. | Oncol Lett | 2016 Feb |
2 |
| 37 | 27103406 | Oxidative stress, microRNAs and cytosolic calcium homeostasis. | Cell Calcium | 2016 Sep |
3 |
| 38 | 27362808 | miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. | Cell Death Dis | 2016 Jun 30 |
7 |
| 39 | 27542265 | Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. | Oncotarget | 2016 Sep 20 |
2 |
| 40 | 28063065 | Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205. | Cancer Chemother Pharmacol | 2017 Feb |
1 |
| 41 | 28304186 | miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan. | J Renin Angiotensin Aldosterone Syst | 2016 Jul-Sep |
3 |
| 42 | 28350117 | Reduced expression of miR‑205‑5p promotes apoptosis and inhibits proliferation and invasion in lung cancer A549 cells by upregulation of ZEB2 and downregulation of erbB3. | Mol Med Rep | 2017 May |
1 |
| 43 | 28384720 | miRNA Copy Number Variants Confer Susceptibility to Acute Anterior Uveitis With or Without Ankylosing Spondylitis. | Invest Ophthalmol Vis Sci | 2017 Apr 1 |
3 |
| 44 | 28427207 | miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells. | Oncotarget | 2017 Apr 25 |
4 |
| 45 | 28536008 | Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. | Cancer Lett | 2017 Aug 28 |
2 |
| 46 | 28719220 | EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer. | Mol Pharm | 2017 Sep 5 |
1 |
| 47 | 28781955 | ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer. | FEBS Open Bio | 2017 Aug |
8 |
| 48 | 28792704 | Epigenetic Modification of MicroRNA-205 and its Association with Glioblastoma Multiform. | Clin Lab | 2017 Jul 1 |
1 |
| 49 | 28861326 | LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p. | Am J Cancer Res | 2017 |
1 |
| 50 | 28979703 | MicroRNA-205-5p regulates the chemotherapeutic resistance of hepatocellular carcinoma cells by targeting PTEN/JNK/ANXA3 pathway. | Am J Transl Res | 2017 |
5 |